We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Motif Bio Plc | LSE:MTFB | London | Ordinary Share | GB00BVVT4H71 | ORD 0.01P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.50 | 0.40 | 0.55 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMMTFB
RNS Number : 3120G
Motif Bio PLC
01 March 2018
Motif Bio plc
("Motif Bio" or the "Company")
Grant of share options to senior management
Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announces that the Company has granted a total of 4,750,000 options to purchase ordinary shares of 1 pence each of Motif Bio ("Ordinary Shares") under the Company's 2015 share option plan. The options have an exercise price of 36.1 pence per Ordinary Share, being the closing price of the Ordinary Shares on February 28, 2018, the date of grant of the options.
Graham Lumsden, Chief Executive Officer, has been granted 3,000,000 options to purchase Ordinary Shares which vest over a four-year period, 2,000,000 of which are based on meeting certain performance targets. Jonathan Gold, Interim Chief Financial Officer, has been granted 1,000,000 options to purchase Ordinary Shares, 750,000 of which vest over a four-year period and are based on meeting certain performance targets and 250,000 of which will vest over a 12-month period beginning at the end of his interim assignment. Dr David Huang, Chief Medical Officer, was granted 750,000 options to purchase Ordinary Shares which vest over a four-year period.
For further information, please contact:
Hot Features
Premium
Motif Bio plc info@motifbio.com
Graham Lumsden (Chief Executive
Officer)
Peel Hunt LLP (NOMAD & BROKER) + 44 (0)20 7418 8900
Dr Christopher Golden
Oliver Jackson
Northland Capital Partners
Limited (BROKER) +44 (0)203 861 6625
David Hignell/John Howes/Rob
Rees
Walbrook PR Ltd. (UK FINANCIAL
PR & IR) +44 (0) 20 7933 8780
Paul McManus/Helen Cresswell/ motifbio@walbrookpr.com
Lianne Cawthorne
MC Services AG (EUROPEAN
IR) +49 (0)89 210 2280
Raimund Gabriel raimund.gabriel@mc-services.eu
The Trout Group (US IR) + 1 (646) 378-2936
Meggie Purcell mpurcell@troutgroup.com
Russo Partners (US PR) +1 (858) 717-2310
+1 (212) 845-4272
David Schull david.schull@russopartnersllc.com
Travis Kruse, Ph.D. travis.kruse@russopartnersllc.com
1. Details of the person discharging managerial
responsibilities / person closely associated
--- ----------------------------------------------------------------
a. Name Graham Lumsden
--- ------------------------------ --------------------------------
2. Reason for the notification
--- ----------------------------------------------------------------
a. Position/status Chief Executive Officer
--- ------------------------------ --------------------------------
b. Initial notification Initial
/Amendment
--- ------------------------------ --------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ----------------------------------------------------------------
a. Name Motif Bio plc
--- ------------------------------ --------------------------------
b. LEI 54930080DN00QTIUUU84
--- ------------------------------ --------------------------------
4. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ----------------------------------------------------------------
a. Description Options over ordinary shares of
of the 1p each
Financial
instrument,
type
of instrument GB00BVVT4H71
Identification
code
--- ------------------------------ --------------------------------
b. Nature of Grant of options to a PDMR
the transaction
--- ------------------------------ --------------------------------
c. Price(s) Price(s) Volume(s)
and volume(s) --------- ----------
0p 3,000,000
--------- ----------
--- ------------------------------ --------------------------------
d. Aggregated
information N/A
* Aggregated volume
* Price
--- ------------------------------ --------------------------------
e. Date of the 2018-02-28
transaction
--- ------------------------------ --------------------------------
f. Place of N/A
the transaction
--- ------------------------------ --------------------------------
5. Details of the person discharging managerial
responsibilities / person closely associated
--- ----------------------------------------------------------------
a. Name Jonathan Gold
--- ------------------------------ --------------------------------
6. Reason for the notification
--- ----------------------------------------------------------------
a. Position/status Interim Chief Financial Officer
--- ------------------------------ --------------------------------
b. Initial notification Initial
/Amendment
--- ------------------------------ --------------------------------
7. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ----------------------------------------------------------------
a. Name Motif Bio plc
--- ------------------------------ --------------------------------
b. LEI 54930080DN00QTIUUU84
--- ------------------------------ --------------------------------
8. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ----------------------------------------------------------------
a. Description Options over ordinary shares of
of the 1p each
Financial
instrument,
type
of instrument GB00BVVT4H71
Identification
code
--- ------------------------------ --------------------------------
b. Nature of Grant of options to a PDMR
the transaction
--- ------------------------------ --------------------------------
c. Price(s) Price(s) Volume(s)
and volume(s) --------- ----------
0p 1,000,000
--------- ----------
--- ------------------------------ --------------------------------
d. Aggregated
information N/A
* Aggregated volume
* Price
--- ------------------------------ --------------------------------
e. Date of the 2018-02-28
transaction
--- ------------------------------ --------------------------------
f. Place of N/A
the transaction
--- ------------------------------ --------------------------------
9. Details of the person discharging managerial
responsibilities / person closely associated
---- ----------------------------------------------------------------
a. Name Dr David Huang
---- ------------------------------ --------------------------------
10. Reason for the notification
---- ----------------------------------------------------------------
a. Position/status Chief Medical Officer
---- ------------------------------ --------------------------------
b. Initial notification Initial
/Amendment
---- ------------------------------ --------------------------------
11. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------
a. Name Motif Bio plc
---- ------------------------------ --------------------------------
b. LEI 54930080DN00QTIUUU84
---- ------------------------------ --------------------------------
12. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- ----------------------------------------------------------------
a. Description Options over ordinary shares of
of the 1p each
Financial
instrument,
type
of instrument GB00BVVT4H71
Identification
code
---- ------------------------------ --------------------------------
b. Nature of Grant of options to a PDMR
the transaction
---- ------------------------------ --------------------------------
c. Price(s) Price(s) Volume(s)
and volume(s) --------- ----------
0p 750,000
--------- ----------
---- ------------------------------ --------------------------------
d. Aggregated
information N/A
* Aggregated volume
* Price
---- ------------------------------ --------------------------------
e. Date of the 2018-02-28
transaction
---- ------------------------------ --------------------------------
f. Place of N/A
the transaction
---- ------------------------------ --------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBIGDDUDDBGII
(END) Dow Jones Newswires
March 01, 2018 02:02 ET (07:02 GMT)
1 Year Motif Bio Chart |
1 Month Motif Bio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
